Related Experiment Video
Updated: Sep 19, 2025

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Tinea Capitis Caused by Trichophyton tonsurans That Responded to Fosravuconazole
Ayaka Miyata1, Utako Kimura1,2,3, Hiromitsu Noguchi3,4
1Department of Dermatology, Juntendo University Urayasu Hospital.
None:
We herein report the first case of tinea capitis caused by Trichophyton tonsurans that responded to fosravuconazole (F-RVCZ). Clinical improvement was achieved within six weeks after the start of F-RVCZ therapy, and the hairbrush culture test was negative. After treatment discontinuation, no relapse of symptoms was observed, and subsequent hairbrush cultures remained negative. F-RVCZ has been suggested as a rapidly acting and effective therapeutic agent for tinea capitis caused by this infection. Treatment of tinea capitis requires oral antifungal therapy; however, side effects associated with long-term administration sometimes occur. Oral treatment with F-RVCZ was found to be effective and had the advantage of relatively few side effects.
More Related Videos
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Microsporidia
Fungal Group Zygomycota
Fungal Phylum Basidiomycota
Fungal Phylum Ascomycota
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...

